Paper40487574
Challenges in implementing 2021 WHO CNS tumor classification in a resource-limited setting.
Gilani A and 4 others. Neurooncol Pract, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Challenges in implementing 2021 WHO CNS tumor classification in a resource-limited setting. Papers, record 40487574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40487574
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Challenges in implementing 2021 WHO CNS tumor classification in a resource-limited setting.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28587626 | Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours. | Acta Neuropathol Commun | 2017 | https://conductscience.org/library/papers/28587626 | PubMed |
| 2 | 36591633 | Gender disparities in brain tumours: A Pakistan brain tumour epidemiology study analysis. | J Pak Med Assoc | 2022 | https://conductscience.org/library/papers/36591633 | PubMed |
| 3 | 23161096 | LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). | Acta Neuropathol | 2012 | https://conductscience.org/library/papers/23161096 | PubMed |
| 4 | 38764578 | Pediatric neuropathology practice in a low- and middle-income country: capacity building through institutional twinning. | Front Oncol | 2024 | https://conductscience.org/library/papers/38764578 | PubMed |
| 5 | 23575898 | Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. | Acta Neuropathol | 2013 | https://conductscience.org/library/papers/23575898 | PubMed |
| 6 | 29372318 | cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC). | Acta Neuropathol | 2018 | https://conductscience.org/library/papers/29372318 | PubMed |
| 7 | 33099686 | Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma. | Acta Neuropathol | 2020 | https://conductscience.org/library/papers/33099686 | PubMed |
| 8 | 31595628 | Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors. | Pediatr Blood Cancer | 2020 | https://conductscience.org/library/papers/31595628 | PubMed |
| 9 | 39026106 | Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations. | Acta Neuropathol | 2024 | https://conductscience.org/library/papers/39026106 | PubMed |
| 10 | 34555175 | Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics. | Neuro Oncol | 2022 | https://conductscience.org/library/papers/34555175 | PubMed |
| 11 | 37574221 | Announcing the Asian Oceanian Society of Neuropathology guidelines for Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions (AOSNP-ADAPTR). | Brain Pathol | 2024 | https://conductscience.org/library/papers/37574221 | PubMed |
| 12 | 36591621 | The Pakistan Brain Tumour Epidemiology Study. | J Pak Med Assoc | 2022 | https://conductscience.org/library/papers/36591621 | PubMed |
| 13 | 28733933 | Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/28733933 | PubMed |
| 14 | 34725697 | DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology. | Neuro Oncol | 2021 | https://conductscience.org/library/papers/34725697 | PubMed |
| 15 | 38312227 | Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma. | Neurooncol Adv | 2024 | https://conductscience.org/library/papers/38312227 | PubMed |
| 16 | 34185076 | The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. | Neuro Oncol | 2021 | https://conductscience.org/library/papers/34185076 | PubMed |
| 17 | 38937309 | Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location. | J Neurooncol | 2024 | https://conductscience.org/library/papers/38937309 | PubMed |
| 18 | 34297434 | Myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arising in midbrain tectum with multifocal CSF dissemination. | Brain Pathol | 2022 | https://conductscience.org/library/papers/34297434 | PubMed |
| 19 | 37476329 | Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. | Neurooncol Adv | 2023 | https://conductscience.org/library/papers/37476329 | PubMed |
| 20 | 25427834 | ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. | Acta Neuropathol | 2015 | https://conductscience.org/library/papers/25427834 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42877419 | High-grade gliomas where resources define survival: a systematic review and meta-analysis of outcomes, surgical access, and molecular diagnostic gaps in low- and middle-income countries. | Front Oncol | 2026 | https://conductscience.org/library/papers/42877419 | PubMed |
| 42707049 | Molecular profiling of pediatric medulloblastoma in Kazakhstan: Genomic alterations, subgroup distribution, and survival. | Brain Pathol | 2026 | https://conductscience.org/library/papers/42707049 | PubMed |
| 42666069 | AOSNP-ADAPTR resource level-based recommendations on practical diagnostic strategies for medulloblastomas and other embryonal tumors. | Brain Pathol | 2026 | https://conductscience.org/library/papers/42666069 | PubMed |
| 42180673 | H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42180673 | PubMed |
| 41644502 | Magnetic resonance imaging findings of dysembryoplastic neuroepithelial tumors and low-grade astrocytomas. | J Chin Med Assoc | 2026 | https://conductscience.org/library/papers/41644502 | PubMed |
| 40487579 | The 2021 WHO classification of tumors of the central nervous system: Responding to the challenge in low- and middle-income countries. | Neurooncol Pract | 2025 | https://conductscience.org/library/papers/40487579 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IDH1 | 3417 | PubTator's text mining | https://conductscience.org/library/genes/3417 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40487574
GET https://conductscience.org/api/papers/v1/40487574/references?page=2